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Case Report
INTRODUCTION
COVID-19 infection usually pre-
sents with respiratory symptoms and 
fever, however there are several unusu-
al extrapulmonary and atypical initial 
presentations of COVID-19 infection 
reported (1). Recent literature has shown 
that SARS-CoV-2 causes endotheli-
al dysfunction leading to thrombosis 
mostly venous (2). Arterial thrombosis 
occurs rarely, usually in severe CO-
VID-19 patients (2-6).
CASE REPORT
A sixty-year-old female patient was 
admitted to the hospital because of acu-
te onset of pain in the right leg and foot 
with cramping. A week before admissi-
on she was treated for urinary infection. 
Her husband had a cold ten days prior, 
but the SARS-CoV-2 test was not per-
formed, and she had no known contact 
with a confirmed SARS-CoV-2 infec-
ted person. Laboratory tests performed 
revealed thrombocytosis 514x109/L, C-
reactive protein (CRP) of 56.2 mg/L, 
prothrombin time (PT) of 0.57, lactate 
dehydrogenase (LDH) was 293 U/L and 
D-dimer level was 4.26 mg/L. An an-
gio-CT scan performed upon admission 
identified free-floating abdominal aorta 
thrombus causing near-complete occlu-
sion of its lumen (Figure 1). Minimal 
aortic wall calcification in the aortoiliac 
segment and lack of collaterals indicated 
acute occlusion. Distal embolism of both 
deep femoral arteries and the right po-
pliteal artery were also present (Figure 
2). The patient had no previous severe 
comorbidities or known cardiovascular 
risk factors that could have caused the 
arterial embolisms. 
The preoperative chest X-ray 
showed signs of bilateral peripheral opa-
cities consistent with viral pneumonia, 
with 97% O2 saturation at admission. 
Although our patient had no fever, res-
piratory or any other COVID-19-asso-
ciated symptoms, routine preoperative 
polymerase chain reaction (PCR) test 
of the throat and nasopharyngeal swab 
came positive. The patient underwent 
endovascular thrombectomy with the 
retrieval of a large acute thrombus, re-
sulting in significant clinical and ra-
diological improvement. She was also 
treated with anticoagulants. Control 
angio-CT showed a complete resolution 
of aortic thrombus. There was no fever 
or respiratory symptoms neither prior to 
development of thrombosis nor during 
the hospitalization period.  She had O2 
saturation 95% during hospitalization 
(normal values) and was discharged with 
clinical improvement.
DISCUSSION
It is well known that patients with 
COVID-19 may have coagulation ab-
normalities (1). Recently several studies 
regarding arterial embolism have been 
published (2-8). Cantador reported a 1% 
incidence of systemic arterial thrombo-
tic events, most of them were presented 
as ischemic stroke (3). In that study only 
three patients developed acute lower 
limb ischemia and all of them had severe 
COVID-19 with bilateral pneumonia (3). 
Most of the COVID-19 patients who la-
ter presented with thromboembolic com-
plications had an onset of severe respi-
ratory symptoms before acute ischemia 
and thrombosis could be explained by 
accompanied hypoxia as an emerging 
cofactor in the thrombosis stimulation 
(3, 4, 6, 7, 9).
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Among the COVID-19 patients with 
acute leg ischemia, there were mostly 
thromboembolic events of the femoral or 
popliteal artery with frequent history of 
cardiovascular risk factors (3, 4). Cases 
like ours, with large arterial thrombosis 
that nearly occluded aorta with massive 
peripheral embolic occlusion on both 
legs, were rare, especially in patients 
without previous cardiovascular disease 
or risk factors (10, 11). Vulliamy and al 
reported two cases of major occlusive ar-
terial events in patients with confirmed 
symptomatic COVID-19 who did not 
have previous peripheral artery disease, 
but they developed respiratory symptoms 
before the arterial thrombosis (6). A lar-
ge thrombus burden and involvement of 
proximal vessels were noticed in the stu-
dy of Goldman et al (12). In their study 
the ischemic leg symptoms were initial 
symptoms in five patients; however, it is 
not clear whether these patients develo-
ped COVID-19 symptoms afterwards 
during hospitalization.
As far as we know the available li-
terature reported respiratory symptoms 
either before or after aortic thrombosis 
onset. However, our patient never mani-
fested any respiratory symptoms or fe-
ver, and she had a large thrombus burden 
without a history of known atherosclero-
sis, prothrombotic disease or atrial fibri-
llation. The pathogenesis of hypercoagu-
lability in COVID-19 is still unclear. It 
seems that there is direct SARS-CoV-2 
viral invasion of endothelial cells that 
could contribute to clot formation (2). 
Platelets have a major role in thrombo-
sis which is one kind of defence from 
pathogens recently termed the "immu-
nothrombosis" (9). Although platelets 
engulf certain viruses such as HIV or 
HCV, the immunothrombosis is likely 
for bacterial infections but less probable 
for viral infections (9).
Increased platelet count was frequ-
ently reported in the COVID-19 patients, 
especially compared to other coronavirus 
infections (7, 8, 13). Although the CO-
VID-19 patients can have high, normal, 
or low platelet count, thrombocytopenia 
appears to predict the severity of CO-
VID-19 infection (13). It is well known 
that an arterial thrombus is the characte-
ristically platelet-rich thrombus formed 
around ruptured atherosclerotic plaques 
or damaged endothelium. Progression of 
thrombus is determined by endothelium 
and through degradation of fibrin which 
can explain large thrombus and elevated 
levels of D-dimer in the COVID-19 pati-
ents (9, 12, 14). Our patient had a high D-
dimer value which can be expected due 
to large acute clots. It is reported that the 
elevation of D-dimer is correlated with 
severe COVID-19 infection (14).
If the endothelial injury is present 
together with thrombocytosis, a for-
mation of the large arterial thrombus 
can occur. Although it seems that the 
incidence of arterial thrombosis in the 
COVID-19 patients is low compared to 
venous thrombosis, its implications or 
consequences can be devastating thus we 
should be alert to arterial thrombosis due 
to the new onset of hypercoagulable sta-
te in SARS-CoV-2 infection (2). Someti-
mes COVID-19 patients develop arterial 
thrombosis despite the antithrombotic 
prophylaxis (5). Antiaggregation therapy 
might be required due to the role of pla-
telets in the arterial thrombus formation. 
CONCLUSION
COVID-19 patients can develop 
arterial thrombosis as an infection pre-
senting feature even without respiratory 
symptoms or fever. Thus, we should pay 
attention to this unusual and someti-
mes the only presentation of the SARS-
CoV-2 infection, that not only endangers 
the affected individual, but it could also 
cause the epidemiologic consequences 
with increased risk of viral transmissi-
on among vulnerable intrahospital po-
pulation unless timely recognized. It is 
important that every patient presenting 
with arterial thrombosis, especially 
with floating thrombus, regardless of the 
typical COVID-19 symptoms absence, 
gets tested for SARS-CoV-2. The exact 
mechanism of the thromboembolism in 
COVID-19, like in majority of other in-
fections, remains mostly controversial 
and needs further investigation.
The work was carried out in Univer-
sity Hospital of Split, Croatia, Spinčiće-
va 1, 21000 Split. Data were extracted 
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Figure 1. 
CT angiography of abdominal aorta: 
Multiplanar reconstruction in coronal plane 
shows a large intraluminal filling defect of the 
abdominal aorta illustrating extensive free-
floating aortic thrombus (arrow).
Figure 2. 
CT angiography of peripheral arteries: 
Coronal MIP reconstruction shows 
thromboembolic occlusion of both deep 
femoral arteries (A, arrows) and occlusion of 
the right popliteal artery (B, arrow).
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Sažetak
MASIVNA TROMBOZA ABDOMINALNE AORTE S DISTALNOM EMBOLIJOM 
KAO JEDINA KLINIČKA MANIFESTACIJA COVID-19 INFEKCIJE
Ivana Štula, Maja Marinović Guić, Sanja Lovrić Kojundžić, Jasenka Gabrić
Infekcija COVID-19 se obično manifestira respiratornim simptomima i vrućicom, no u literaturi je opisano nekoliko neuobi-
čajenih početnih simptoma bolesti. Prikazujemo slučaj bolesnice s trombozom arterije kao jedinom kliničkom prezentacijom ove 
bolesti, bez drugih uobičajenih simptoma vezanih uz COVID-19. Ukoliko se pravovremeno ne prepozna, to može rezultirati odgo-
đenim dijagnosticiranjem i izolacijom suspektnog bolesnika te uzrokovati epidemiološke posljedice i povećani rizik prijenosa virusa 
unutar bolnice u doba pandemije.
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